Bicara Therapeutics Inc (BCAX)
R&D Expenses
$132.08M
TTM · Period ending: · USD
BCAX R&D Expenses
Latest reported$132.08Mperiod ending
Latest reported$132.08Mperiod ending
BCAX TTM R&D Expenses ($30.61M → $132.08M)
TTM R&D Expenses
High-resolution chart · PNG
BCAX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 132,080,000 | |
| 111,105,000 | |
| 97,938,000 | |
| 84,831,000 | |
| 94,878,000 | |
| 85,921,000 | |
| 63,620,000 | |
| 54,299,000 | |
| 45,374,000 | |
| 36,089,000 | |
| 30,613,000 |